# A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis

> **NCT00870467** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 334 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Double-blind adalimumab
- **DRUG:** Double-blind Placebo
- **BIOLOGICAL:** Open-label Adalimumab
- **BIOLOGICAL:** Open-labelAdalimumabRescue

## Key facts

- **NCT ID:** NCT00870467
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-08
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2012-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870467, "A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00870467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*